About MINTPharma
capital
At MintPharma Capital, we are passionate about investing in biotech innovation. We believe in the transformative power of life-changing sciences and are committed to supporting dynamic companies at the forefront of this field.
​
Investing in biotech innovation can be challenging, but we have the expertise and experience to navigate this complex field. Our team of experts includes seasoned professionals with deep expertise in biotech and life sciences who bring a wealth of knowledge and insights to our investment decisions.
INVESTMENT CRITERIA
-
MintPharma Capital typical investment is between $2-7 million, and we often act as the lead investor in seed or series A rounds.
-
MintPharma Capital targets companies with innovative therapies in government protected reimbursement classes as well as new indications where no FDA approved drug or cleared device exists. We have conviction in the potential to significantly reduce cost while improving patient care.
-
We believe a cost reduction strategy layer with strong scientific innovation will have a better chance of potential acquisition and significant valuation inflection points if successful.